Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation (TMS)
Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: BeerYaakov Mental Health Center
Listed as NCT00951782, this PHASE2/PHASE3 trial focuses on Chronic Obstructive Pulmonary Disease and Smoking and remains completed. Sponsored by BeerYaakov Mental Health Center, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BeerYaakov Mental Health Center
For direct contact, visit the study record on ClinicalTrials.gov .